Mergers & Acquisitions - Shire


Current filters:


Popular Filters

201 to 225 of 909 results

France’s Servier offers to take full control of Egis Pharma

France’s Servier offers to take full control of Egis Pharma


French privately-held drugmaker Servier has made a voluntary public offer to buy all outstanding shares…

EGIS PharmaceuticalsEuropeMergers & AcquisitionsPharmaceuticalServier

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned


USA-based Retrophin (OTCQB: RTRX) has made a proposal to the board of directors of Transcept Pharmaceuticals…

Mergers & AcquisitionsPharmaceuticalRetrophinTranscept Pharma

First-half 2013 sees fall in licensing, says Evaluate


Despite a positive start to the year characterized by healthy initial public offering (IPO) activity…

FinancialLicensingMergers & AcquisitionsPharmaceutical

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market


Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

UK's BTG sells brachytherapy business for $5million

UK's BTG sells brachytherapy business for $5million


UK-based specialty pharma company BTG (LSE: BTG) has sold its brachytherapy business to German company…

BTGEuropeMergers & AcquisitionsPharmaceutical

Chiesi Farmaceutici to acquire full ownership of Cornerstone Therapeutics


Privately-held Italian drugmaker Chiesi Farmaceutici and specialty US firm Cornerstone Therapeutics (Nasdaq:…

Chiesi FarmaceuticiCornerstone TherapeuticsMergers & AcquisitionsPharmaceutical

Adcock Ingram agrees takeover terms with CFR


Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Cellceutix acquires PolyMedix assets from bankruptcy court


US clinical-stage biopharma firm Cellceutix (OTCBB: CTIX) has acquired substantially all of the assets…

BiotechnologybrilacidinCellceutixMergers & AcquisitionsPharmaceuticalPolyMedixPrurisol

Italy's Recordati to acquire Spanish drugmaker


In a second takeover deal this year, Italian drugmaker Recordati (RC: MI) says it has signed agreements…

CitrafleetGastro-intestinalsLab Casen FleetMergers & AcquisitionsPharmaceuticalRecordatiWomen's Health

bioMerieux makes significant US acquisition in molecular biology


French in vitro diagnostics firm bioMerieux (Euronext: BIM) has entered into an agreement to acquire…

BioFire DiagnosticsBioMerieuxMergers & AcquisitionsPharmaceutical

Otsuka confirms takeover bid for Astex Pharmaceuticals for $886 million


Following heavy speculation on Wednesday (see The Pharma Letter story earlier today), this morning Japanese…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Otsuka said to be buying Astex Pharma


Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Russian billionaire to acquire control of Veropharm


Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Added benefit of lisdexamfetamine not proven, says German watchdog


Ireland-headquartered Shire's (LSE: SHP) Elvanse (lisdexamfetamine dimesylate) demonstrated no added…

ElvanseEuropelisdexamfetamine dimesylateNeurologicalPharmaceuticalPricingRegulationShireVyvanse

Meda acquires US respiratory company


Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Endo Health expends $225 million on generic acquisition


USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Sangamo BioSciences to buy Ceregene


In its first takeover bid since 2001, US drugmaker Sangamo BioSciences (Nasdaq: SGMO) has signed a definitive…

BiotechnologyCERE-110CeregeneMergers & AcquisitionsNeurologicalOphthalmicsSangamo BioSciences

Akorn buys rival generic drugmaker for $640 million


USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Immune Pharma and EpiCept complete merger


Israel-based Immune Pharmaceuticals (Nasdaq OMX Stockholm Exchange: IMNP) says it has now completed its…

AmiKetEpiCeptImmune PharmaceuticalsMergers & AcquisitionsPharmaceutical

Onyx Pharma accepts increased bid from Amgen


Amgen (Nasdaq: AMGN), the world largest independent biotech group, said on Sunday (August 25) that the…

AmgenBayerBiotechnologyKyprolisMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizer

AstraZeneca nabs Amplimmune for $500 million


In a further bid to expand its ailing research portfolio, Anglo-Swedish drug major AstraZeneca (LSE:…

AmplimmuneAstraZenecaBiotechnologyMergers & AcquisitionsOncologyPharmaceutical

Actelion bid for Ceptaris looks secured as FDA approves Valchlor


Privately-held USA-based Ceptaris Therapeutics revealed yesterday (August 26) that the US Food and Drug…

ActelionBiotechnologyCeptaris TherapeuticsDermatologicalsMergers & AcquisitionsNorth AmericaRegulationValchlor

Chiesi expands rare disease portfolio with acquisition


Privately-owned Italian drugmaker Chiesi Group has signed, through its UK affiliate, a definitive agreement…

BiotechnologyChiesi FarmaceuticiLamazymMergers & AcquisitionsPharmaceuticalRare diseasesZymenex

Shire and Santaris extend strategic alliance


Danish privately held clinical-stage biopharmaceutical company Santaris Pharma says that its long term…

BiotechnologyLicensingPharmaceuticalRare diseasesResearchSantaris PharmaShire

201 to 225 of 909 results

Back to top